Gossamer Bio Inc

GOSSNASDAQ · USD
11.43USD+11.29 (+3.54%)
152

Gossamer Bio Inc (GOSS) Implied Volatility Current

GOSS's 30 day implied volatility is 210.91%, with an IV Rank of 42.26%. This is an average IV Rank versus the past year, meaning Gossamer Bio Inc options are fairly priced and currently offer no clear edge to buyers or sellers. GOSS's 30 day historical volatility sits at 123.75%, which means implied volatility is running 87.16 points above historical volatility, as of Nov 17, 2026.

Read more

Tracking GOSS implied volatility helps you spot when Gossamer Bio Inc options are historically cheap or expensive, and where the best trades are hiding. When GOSS IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor GOSS implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking GOSS IV rank helps you see whether GOSS's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis.

Implied Volatility

IV Rank
42.26%IV Rank
Moderate

IV is slightly elevated. Premiums are richer, leaning toward sellers.

Implied Volatility (30d)210.91%

IV Rank42.26%

Historical Volatility (30d)123.75%

IV Minus HV+87.16%

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →